What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Read More

Biosimilars in the EU – Information guide for healthcare professionals – unofficial Ukrainian translation now available

8 February 2021

External Resource

OPEN UNOFFICIAL UKRAINIAN TRANSLATION

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Read More

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Factsheet

Read More

The total clinical experience with biosimilar medicines exceeds 2 billion patient treatment days

16 December 2020

Infographic

Read More

Biosimilar medicines are available in therapy areas which represent 65% of the biologics market by value

16 December 2020

Infographic

Read More

In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

16 December 2020

Infographic

Read More

Growing number of biologic therapies offers future opportunities for biosimilar development

16 December 2020

Infographic

Read More

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

Educational material on biosimilar medicines, developed by IGBA (International Generic and Biosimilar Medicines Association)

2 November 2020

External Resource

Read more

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]
Medicines For Europe